Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Inventory (2017 - 2025)

Historic Inventory for Inspire Medical Systems (INSP) over the last 9 years, with Q4 2025 value amounting to $145.3 million.

  • Inspire Medical Systems' Inventory rose 8134.88% to $145.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $145.3 million, marking a year-over-year increase of 8134.88%. This contributed to the annual value of $145.3 million for FY2025, which is 8134.88% up from last year.
  • According to the latest figures from Q4 2025, Inspire Medical Systems' Inventory is $145.3 million, which was up 8134.88% from $141.8 million recorded in Q3 2025.
  • Inspire Medical Systems' Inventory's 5-year high stood at $145.3 million during Q4 2025, with a 5-year trough of $11.4 million in Q1 2021.
  • In the last 5 years, Inspire Medical Systems' Inventory had a median value of $24.2 million in 2022 and averaged $49.5 million.
  • Per our database at Business Quant, Inspire Medical Systems' Inventory plummeted by 3101.97% in 2022 and then soared by 21267.32% in 2024.
  • Over the past 5 years, Inspire Medical Systems' Inventory (Quarter) stood at $17.2 million in 2021, then tumbled by 31.02% to $11.9 million in 2022, then surged by 185.08% to $33.9 million in 2023, then soared by 136.44% to $80.1 million in 2024, then surged by 81.35% to $145.3 million in 2025.
  • Its last three reported values are $145.3 million in Q4 2025, $141.8 million for Q3 2025, and $121.6 million during Q2 2025.